Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2016 by ViiV Healthcare
Sponsor:
Collaborators:
INC Research
GlaxoSmithKline
Information provided by (Responsible Party):
ViiV Healthcare
ClinicalTrials.gov Identifier:
NCT01137981
First received: March 25, 2010
Last updated: February 18, 2016
Last verified: February 2016